Dendrimer Delivery of Oligonucleotides

References

• Akhtar S., Juliano R. L. Liposome delivery of antisense oligonucleotides: Adsorption and efflux characteristics of phosphorothioate oligodeoxynucleotides. J. Controlled Release 1992; 22: 47–56
   Web of Science ®Google Scholar
• Akhtar S., Kole R., Juliano R. L. Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera. Life Sci. 1991; 49: 1793–1801
   PubMed Web of Science ®Google Scholar
• Asseline U., Hau J.-F., Czernecki S., Le Diguarher T., Perlat M.-C., Valery J.-M., Thuong M. T. Synthesis and physiochemical properties of oligonucleotides built with either α-L or β-L nucleotides units and covalently linked to an acridine derivative. Nucleic Acids Res. 1991; 19: 4067–4074
   PubMed Web of Science ®Google Scholar
• Barth R. F., Adams D. M., Soloway A. H., Alam F., Darby M. V. Boronated Starburst dendrimer–monoclonal antibody immunoconjugates: Evaluation as a potential delivery system for neutron capture therapy. Bioconjug. Chem. 1994; 5: 58–66
   PubMed Web of Science ®Google Scholar
• Barth R. R., Soloway A. H. Boron neutron capture therapy of primary and metastatic brain tumors. Mol. Chem. Neuropathol. 1994; 21: 139–154
   PubMedGoogle Scholar
• Bennett C. F., Chiang M.-Y., Chan H., Shoemaker J. E. E., Mirabelli C. K. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 1992; 41: 1023–1033
   PubMed Web of Science ®Google Scholar
• Chiasson B. J., Hooper M. L., Murphy P. R., Robertson H. A. Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain. Eur. J. Pharmacol. 1992; 227: 451–453
   PubMed Web of Science ®Google Scholar
• Collins J. F., Herman P, Schurch C., Bagby G. C. c-myc antisense oligonucleotides inhibit the colony-forming capacity of Colo 320 colonic carcinoma cells. J. Clin. Invest. 1992; 89: 1523–1527
   PubMed Web of Science ®Google Scholar
• Degols G., Leonetti J.-P., Benkirane M., Devaux C., Lebleu B. Poly(l-lysine)-conjugated oligonucleotides promote sequence-specific inhibition of acute HIV-1 infection. Antisense Res. Dev. 1992; 2: 293–301
   PubMedGoogle Scholar
• Gray G. D., Hernandez O. M., Hebel D., Root M., Pow-Sang J. M., Wickstrom E. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice. Cancer Res. 1993; 53: 577–580
   PubMed Web of Science ®Google Scholar
• Haensler J., Szoka F. C. J. Polyamidoamine cascade polymers mediate efficient transfection of cell in culture. Bioconjug. Chem. 1994; 4: 372–379
   Web of Science ®Google Scholar
• Higgins K. A., Perez J. R., Coleman T. A., Dorshkind K., McComas W. A., Sarmiento U. M., Rosen C. A., Narayanan R. Antisense inhibition of the p65 subunit of NF-KB blocks tumorigenicity and causes tumor regression. Proc. Natl. Acad. Sci. USA 1993; 90: 9901–9905
   PubMed Web of Science ®Google Scholar
• Hughes J. A., Avrutskaya A. V., Juliano R. L. The influence of base composition on cellular transport and membrane binding of oligonucleotides. Antisense Res. Dev. 1994; 4: 452–459
   Google Scholar
• Jaaskelainen I., Monkkonen J., Urtti A. Oligonucleotide-cationic liposome interactions. A physicochemical study. Biochim. Biophys. Acta 1994; 1195: 115–123
   PubMed Web of Science ®Google Scholar
• Manfredini R., Grande A., Tagliafico E., Barbieri D., Zucchini P., Citro G., Zupi G., Franceshi C., Torelli U., Ferrari S. Inhibition of c-fos expression by an antisense oligomer causes apoptosis of HL60 cells induced to granulocytic differentiation. J. Exp. Med. 1993; 178: 381–389
   PubMed Web of Science ®Google Scholar
• Merchant K. M. c-fos antisense oligonucleotide specifically attenuates haloperidol-induced increases in neurotensin/neuromedin-N messenger RNA expression in rat dorsal striatum. Mol. Cell. Neurosci. 1994; 5: 336–344
   PubMed Web of Science ®Google Scholar
• Milligan J. F., Jones R. J., Froehler B. C., Matteucci M. D. Development of antisense therapeutics—Implications for cancer gene therapy. Gene Ther. Neoplastic Dis. 1994; 716: 228–241
   Web of Science ®Google Scholar
• Mizutani T., Hayashi M., Maeda A., Yamashita T., Isogai H., Namioka S. Inhibition of mouse hepatitis virus multiplication by an oligonucleotide complementary to the leader RNA. J. Vet. Med. Sci. 1992; 54: 465–472
   PubMed Web of Science ®Google Scholar
• Moorefield C. N., Newkome G. R. A review of dendritic macromolecules. Adv. Dendritic Macromol. 1994; 1: 1–67
   Google Scholar
• Murakami A. N. M., Nakatsuji Y., Nagahara S., Tran-Cong Q., Makino K. Fluorescent-labeled oligonucleotide probes: Detection of hybrid formation in solution by fluorescence polarization spectroscopy. Nucleic Acids Res. 1991; 19: 4097–4102
   PubMed Web of Science ®Google Scholar
• Ojwang J., Okleberry K. M., Marshall H. B., Vu H. M., Huffman J. H., Rando R. F. Inhibition of Friend murine leukemia virus activity by guanosine/thymidine oligonucleotides. Antiviral Res. 1994; 25: 27–41
   PubMed Web of Science ®Google Scholar
• Paria B. C., Dey S. K., Andres G. K. Antisense c-myc effects on preimplantation mouse embryo development. Proc. Natl. Acad. Sci. USA 1992; 89: 10051–10055
   PubMed Web of Science ®Google Scholar
• Praseuth D., Guieysse A. L., Itkes A. V., Helene C. Unexpected effect of an anti-human immunodeficiency virus intermolecular triplex-forming oligonucleotide in an in vitro transcription system due to RNase H-induced cleavage of the RNA transcript. Antisense Res. Dev. 1993; 3: 33–44
   PubMedGoogle Scholar
• Schmit C., Bevierre M. O., Demesmaeker A., Altmann K. H. The effects of 2′- and 3′-alkyl substituents on oligonucleotide hybridization and stability. Bioorg. Med. Chem. Lett. 1994; 4: 1969–1974
   Web of Science ®Google Scholar
• Schrier J. A., Kenley R. A., Williams R., Corcoran R. J., Kim Y., Northey R. P., D'Augusta D., Huberty M. Degradation pathways for recombinant human macrophage colony-stimulating factor in aqueous solution. Pharm. Res. 1993; 10: 933–944
   PubMed Web of Science ®Google Scholar
• Singh P., Moll F., Lin S., Ferzli C., Yu K. S., Koski R. K., Saul R. G., Cronin P. Starburst dendrimers: Enhanced performance and flexibility for immunoassays. Clin. Chem. 1994; 40: 1845–1849
   PubMed Web of Science ®Google Scholar
• Thurnher M., Wagner E., Clausen H., Mechtler K., Rusconi S., Dinter A., Birnstiel M. L., Berger E. G., Cotten M. Carbohydrate receptor-mediated gene transfer to human T leukemic cells. Glycobiology 1994; 4: 429–435
   PubMed Web of Science ®Google Scholar
• Tomalia D. A., Maylor A. M., Goddard W. A. Starburst dendrimers: Molecular-level control of size, shape, surface chemistry, topology and flexibility from atoms to macroscopic matter. Angew. Chem. Mt. Ed. Engl. 1990; 29: 138–175
   Web of Science ®Google Scholar
• Wagner E., Zatloukal K., Cotten M., Kirlappos H., Mechtler K., Curiel D. T., Birnstiel M. L. Coupling of adenovirus to transferrinpolylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci. USA 1992; 89: 6099–6103
   PubMed Web of Science ®Google Scholar
• Wiener E. C., Brechbiel M. W., Brothers H., Magin R. L., Gansow O. A., Tomalia D. A. Dendrimer-based metal chelates: A new class of magnetic resonance imaging contrast agents. Magn. Reson. Med. 1994; 31: 1–8
   PubMed Web of Science ®Google Scholar
• Xu Z., Kahr M., Walker K. L., Wilkins C. L., Moore J. S. Phenylacetylene dendrimers by the divergent, convergent, and double-stage convergent methods. J. Am. Chem. Soc. 1994; 116: 4537–4550
   Web of Science ®Google Scholar